Objective: To study the damage and mechanism of intestinal mucosal barrier function in mice with ulcerative colitis induced by Dextran sulphate sodium (DSS). Methods: Mice models of chronic ulcerative colitis induced by DSS were established. The mice were completely randomized into normal control group and DSS group, 25 mice in each group. The body weight and colon length of the mice were monitored. The pathological examination of colon tissue was confirmed the success of the model and assessed the integrity of the colonic mucosal barrier; Evan's Blue's intestinal permeability analysis assessed the function of colon mucosal barrier; immunofluorescence staining and Western blot were used to evaluate the expression of intestinal mucosal barrier integrity-related proteins. Results: Compared with the normal control group, the DSS group had lower body weight [(25.6±0.7)g vs (23.5±0.7)g, t=2.14, P<0.05], and the colon length was shorter [(7.3±0.4)cm vs (5.6±0.2)cm, t=3.975, P<0.001]; colonic pathological results showed that the intestinal mucosa became thinner and part of the intestinal mucosa was defective; Evan's Blue instilled into the intestinal lumen was more abundant into the intestinal mucosa, and the optical density at 620 nm (OD(620))/colon tissue weight (g) was higher [(0.11±0.01) vs (0.15±0.01), t=4.174, P<0.05]; immunofluorescence and Western blot results showed lower expression of ZO-1, Claudin-1, and F-actin in colonic mucosa. Conclusion: The structure and function of intestinal mucosal barrier in DSS-induced chronic ulcerative colitis mice is impaired.
Objective: To study the damage and mechanism of intestinal mucosal barrier function in mice with ulcerative colitis induced by Dextran sulphate sodium (DSS). Methods:Mice models of chronic ulcerative colitis induced by DSS were established. The mice were completely randomized into normal control group and DSS group, 25 mice in each group. The body weight and colon length of the mice were monitored. The pathological examination of colon tissue was confirmed the success of the model and assessed the integrity of the colonic mucosal barrier; Evan's Blue's intestinal permeability analysis assessed the function of colon mucosal barrier; immunofluorescence staining and Western blot were used to evaluate the expression of intestinal mucosal barrier integrity-related proteins. Results: Compared with the normal control group, the DSS group had lower body weight [(25.6±0.7)g vs (23.5±0.7)g, t=2.14, P<0.05], and the colon length was shorter [(7.3±0.4)cm vs (5.6±0.2)cm, t=3.975, P<0.001]; colonic pathological results showed that the intestinal mucosa became thinner and part of the intestinal mucosa was defective; Evan's Blue instilled into the intestinal lumen was more abundant into the intestinal mucosa, and the optical density at 620 nm (OD(620))/colon tissue weight (g) was higher [(0.11±0.01) vs (0.15±0.01), t=4.174, P<0.05]; immunofluorescence and Western blot results showed lower expression of ZO-1, Claudin-1, and F-actin in colonic mucosa. Conclusion: The structure and function of intestinal mucosal barrier in DSS-induced chronic ulcerative colitismice is impaired.